Salas Eduardo Rene — SEC Form 4 filings
SEC reporting owner CIK 1924188. 6 Form 4 filings on record with FilingPulse; latest filed 2026-02-11.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-06-18 to 2026-02-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) | Director | 3 | — | — | 10 |
| ADMA BIOLOGICS, INC. (ADMA) | Director | 3 | — | — | 5 |
Form 4 filings — Salas Eduardo Rene
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-11 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Disposition to issuer (D): 1,567 @ $132 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 16,757 (derivative) · Disposition to issuer (D): 7,009 (derivative) · Disposition to issuer (D): 4,322 (derivative) · Disposition to issuer (D): 2,951 (derivative) | EDGAR |
| 2025-02-21 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 10,889 @ $0 · Grant/award (A): 16,279 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 20,011 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 1,567 · Option exercise (M): 1,567 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 2,951 (derivative) @ $0 · Grant/award (A): 4,322 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1924188 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →